AstraZeneca Pharma India Ltd. on Thursday reported a net loss for the first quarter of this financial year.
The pharmaceutical firm recorded a net loss of Rs 11.79 crore for the quarter-ended June, as compared to net profit of Rs 53.86 crore in the same quarter of the previous fiscal, according to its stock exchange notification.
Revenue increased by 31.2% year-on-year for the three months ended June, reaching Rs 387.52 crore.
"It's a strong start of the year, with 31% revenue growth and double-digit profit margin (before exceptional item and tax)," said Chief Finance Officer Bhavana Agrawal.
Operating income, or earnings before interest, taxes, depreciation, and amortisation, fell 43% year-on-year to Rs 38.07 crore. The Ebitda margin contracted to 9.8% from 22.8% in the same period last year.
Shares of the company closed 6.60% lower at Rs 6,622.65 apiece, as compared to a 0.87% decline in the NSE Nifty 50. The stock has risen 17.31% year-to-date and 73.69% over the past 12 months.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
